Portfolio Scaling
We've cracked the bigger picture.
Portfolio Intelligence & Acceleration Platform
80%+ of VC-funded startups fail to scale
Pixie is your asymmetric advantage.
Startups on Pixie adhere more closely to scaling fundamentals.
Pixie addresses the fundamental inefficiency in early-stage investment.
Alongside VC evals and fund management advantages, Pixie delivers a returns boost of transformational magnitude..
Systematic de-risking through fundamental analytics and predictive modelling.
You get cost-effective surveillance across the fund. Optimising for growth and identifying mid-tier opportunities at the best price points, for a flatter yield curve.
And dealflow evaluation leaps in efficiency, with Pixie providing the early rubrik - robust intelligence based on empirically validated patterns of successful scale-ups.
A level of data-driven, real-time insight previously unavailable for pre-Series A startups.
Progress monitored. trajectory mapped.
Presuming they have a promising score and you take them on, Pixie continues to work alongside the start up – providing them with a roadmap to achieve the growth outcomes that you have mutually signed up to.
Systematic scaling intelligence provides real-time performance tracking against ScaleUp DNA benchmarks. Portfolio companies receive evidence-based guidance calibrated to their scaling trajectory, with systematic alerts when key scaling indicators require attention - ensuring systematic navigation rather than reactive management.
Systematic portfolio enhancement
Our methodology targets the £150bn scaling inefficiency through systematic intelligence. Portfolio companies demonstrate measurable improvements in scaling velocity and success probability through evidence-based decision-making rather than intuitive scaling approaches.
EIS amplifies Pixie advantage
Pixie qualifies for full EIS relief: 30% immediate tax relief plus CGT exemption provides 61.5% downside protection on systematic scaling intelligence investment.
Portfolio benefits
Enhanced due diligence through objective scaling potential assessment
Reduced portfolio risk via systematic performance prediction
Accelerated scaling velocity through evidence-based guidance
Measurable improvement in portfolio scaling success rates
ScaleUp DNA analysis adds systematic scaling intelligence to your proven investment methodology - additional data that strengthens portfolio decision-making and enhances scaling performance across your investments.
